MYD88 and lymphoma: MYD88 S257D did not only promote cell growth of MYD88 wildtype cells, but, remarkably, was also able to sustain cell growth of MYD88 L265P-addicted lymphoma cells after silencing of endogenous (mutant) MYD88 (Fig. 5).